English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/121227
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Rescuing compound bioactivity in a secondary cell-based screening by using γ-cyclodextrin as a molecular carrier

AuthorsClaveria-Gimeno, Rafael; Vega, Sonia; Grazú, Valeria; Fuente, Jesús M. de la; Lanas, Ángel; Velazquez-Campoy, Adrian; Abian, Olga
KeywordsPrimary and secondary screenings
Drug activity
Antiviral compounds
Cyclodextrins
Vehiculization
Drug delivery
Hepatitis C
NS3 protease
Virus replicon system
Issue DateMar-2015
PublisherDove Press
CitationInternational Journal of Nanomedicine 10: 2249-2259 (2015)
AbstractIn vitro primary screening for identifying bioactive compounds (inhibitors, activators or pharmacological chaperones) against a protein target results in the discovery of lead compounds that must be tested in cell-based efficacy secondary screenings. Very often lead compounds do not succeed because of an apparent low potency in cell assays, despite an excellent performance in primary screening. Primary and secondary screenings differ significantly according to the conditions and challenges the compounds must overcome in order to interact with their intended target. Cellular internalization and intracellular metabolism are some of the difficulties the compounds must confront and different strategies can be envisaged for minimizing that problem. Using a novel screening procedure we have identified 15 compounds inhibiting the hepatitis C NS3 protease in an allosteric fashion. After characterizing biophysically the interaction with the target, some of the compounds were not able to inhibit viral replication in cell assays. In order to overcome this obstacle and potentially improve cellular internalization three of these compounds were complexed with γ-cyclodextrin. Two of them showed a five- and 16-fold activity increase, compared to their activity when delivered as free compounds in solution (while γ-cyclodextrin did not show antiviral activity by itself). The most remarkable result came from a third compound that showed no antiviral activity in cell assays when delivered free in solution, but its γ-cyclodextrin complex exhibited a 50% effective concentration of 5 µM. Thus, the antiviral activity of these compounds can be significantly improved, even completely rescued, using γ-cyclodextrin as carrier molecule.
DescriptionThis work is published under Creative Commons Attribution - Non Commercial (unported, v3.0) License.
Publisher version (URL)http://dx.doi.org/10.2147/IJN.S79480
URIhttp://hdl.handle.net/10261/121227
DOI10.2147/IJN.S79480
ISSN1176-9114
E-ISSN1178-2013
Appears in Collections:(ICMA) Artículos
(IQFR) Artículos
Files in This Item:
File Description SizeFormat 
Rescuing compound.pdf780,32 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.